Tablet brain health check in primary care for memory problems and dementia
Tests a tablet-based memory check to spot cognitive impairment in primary care patients.
Key facts
- Who runs it
- University of California, San Francisco
- Where
- Pasadena, United StatesSee the site
- Trial code
- Registry title
- TabCAT Brain Health Assessment in Primary Care
- Status
- Recruiting
- People taking part
- 180,000 people, planned
- Started
- 27 Jul 2023
- Expected to end
- 31 Dec 2026
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- TabCAT Brain Health Assessment Clinical Pathway
- Record updated
- 31 October 2025
Who can take part
The trial is looking for adult patients seen at 26 Kaiser Southern California primary care clinics. It tests a tablet-based brain health check to find memory and thinking problems, including dementia.
- Age
- 18 years and older (the main analyses use people aged 65 and older)
- Sex
- All sexes
- Main reasons for not taking part
- People under the age of 18 cannot join.
- You need at least one visit at a study clinic during the study period.
Show the full registry criteria (3)Hide the full registry criteria
Who can take part
- Patient with at least one encounter at an intervention clinic during the intervention period
- Age 18+ (limited to 65+ for primary analyses)
Who cannot take part
- Patients under the age of 18
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
- Mild cognitive impairment or dementia
This trial is currently available in United States.
- Kaiser Permanente Southern California Department of Research & EvaluationPasadena, United StatesContact: Huong Q Nguyen, PhDTaking people
About the trial
What the trial wants to find out
Efficient and user-friendly paradigms to detect cognitive impairment, including dementia are needed in primary care. The TabCAT Brain Health Assessment accurately detects cognitive impairment via an appealing tablet interface with automated scoring and EMR integration. This study will evaluate the effectiveness of the paradigm on detection rates and other brain health outcomes via a pragmatic cluster randomized trial in 26 Kaiser Southern California primary care clinics.
The 2 groups in the trial
- TabCAT-Brain Health Assessment Clinical PathwayTreatment being tested
Primary care providers concerned that their patients are exhibiting signs of cognitive decline based on patient, informant (family), or provider concerns will refer them for a TabCAT-BHA assessment and follow-up care.
- Usual Care Clinical PathwayNo study treatment, for comparison
Patients in the control practices will continue with usual care workflows.
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- A Pragmatic Trial of the TabCAT Brain Health Assessment for the Detection of Cognitive Impairment in Primary Care
- Plain-language title
- Tablet brain health check in primary care for memory problems and dementiaGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Criteria questions
- Built from NCT06090578, who can take part
- Record updated
- 31 October 2025